Record #53330
MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)
Publisher
Original paper date
Nov 10, 2015
Original DOI
Country
Institution
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China · Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, China · School of Medicine and Life Sciences, University of Jinan—Shandong Academy of Medical Sciences, Jinan, China
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
38
Same day
0
Post-retraction
4
% post-retraction
9.8%
~4.6 citations/yr before retraction · ~1.5 citations/yr after
— citing papers
Who is still citing this work
Loading…